EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI ) Registry – Informing optimal antiplatelet strategies

Larisa H Cavallari iD, Craig R Lee iD, Francesco Franchi iD, Ellen C Keeley iD, Joseph S Rossi iD, Cameron D Thomas iD, Yan Gong iD, Caitrin W McDonough iD, Petr Starostik iD, Maryam J Al Saeed iD, Latonya Been iD, Natasha Kulick iD und 9 weitere

Clinical and Translational Science · 2024

DOI: 10.1111/cts.70004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2024. Verfasst von Larisa H Cavallari und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of F…. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Cytochrome P-450 CYP2C19, Registries, Precision Medicine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NHGRI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y 12 receptor inhibitor (clopidogrel, prasugrel, or ticagrelor) is indicated after percutaneous coronary intervention (PCI) to reduce the risk of atherothrombotic events. Approximately 30% of the US population has a CYP2C19 no‐function allele that reduces the effectiveness of clopidogrel, but not prasugrel or ticagrelor, after PCI. We have shown improved outcomes with the integration of CYP2C19 genotyping into clinical care to guide the selection of prasugrel or ticagrelor in CYP2C19 no‐function allele carriers. However, the influence of patient‐specific demographic, clinical, and other genetic factors on outcomes with genotype‐guided DAPT has not been defined. In addition, the impact of genotype‐guided de‐escalation from prasugrel or ticagrelor to clopidogrel in patients without a CYP2C19 no‐function allele has not been investigated in a diverse, real‐world clinical setting. The Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry is a multicenter US registry of patients who underwent PCI and clinical CYP2C19 testing. The registry is enrolling a diverse population, assessing atherothrombotic and bleeding events over 12 months, collecting DNA samples, and conducting platelet function testing in a subset of patients. The registry aims to define the influence of African ancestry and other patient‐specific factors on clinical outcomes with CYP2C19 ‐guided DAPT, evaluate the safety and effectiveness of CYP2C19‐ guided DAPT de‐escalation following PCI in a real‐world setting, and identify additional genetic influences of clopidogrel response after PCI, with the ultimate goal of establishing optimal strategies for individualized antiplatelet therapy that improves outcomes in a diverse, real‐world population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionCytochrome P-450 CYP2C19RegistriesPrecision MedicinePlatelet Aggregation InhibitorsClopidogrelTicagrelorPrasugrel HydrochlorideHumansDual Anti-Platelet TherapyAspirinPurinergic P2Y Receptor AntagonistsHemorrhage

Substanzen

Cytochrome P-450 CYP2C19CYP2C19 protein, humanPlatelet Aggregation InhibitorsClopidogrelTicagrelorPrasugrel HydrochlorideAspirinPurinergic P2Y Receptor Antagonists

Autor:innen und Institutionen

  • Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
  • Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Division of Cardiology and McAllister Heart Institute, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Division of Cardiology, Department of Medicine, College of Medicine-Jacksonville, University of Florida, Jacksonville, Florida, USA.
  • Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Department of Pathology, Immunology and Laboratory Medicine; College of Medicine, University of Florida, Gainesville, Florida, USA.

ORCID-Profile: Larisa H Cavallari, Craig R Lee, Francesco Franchi, Ellen C Keeley, Joseph S Rossi, Cameron D Thomas, Yan Gong, Caitrin W McDonough, Petr Starostik, Maryam J Al Saeed, Latonya Been, Natasha Kulick, Jean Malave, Ian R Mulrenin, Anh B Nguyen, Joshua N Terrell, Amber L Beitelshees, Almut G Winterstein, Dominick J Angiolillo

Förderung

  • NHLBI NIH HHS
  • NHGRI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Cavallari, L. H., Lee, C. R., Franchi, F., Keeley, E. C., Rossi, J. S., Thomas, C. D., Gong, Y., McDonough, C. W., Starostik, P., Al Saeed, M. J., Been, L., Kulick, N., Malave, J., Mulrenin, I. R., Nguyen, A. B., Terrell, J. N., Tillotson, G., Beitelshees, A. L., Winterstein, A. G., …, & Angiolillo, D. J. (2024). Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI ) Registry – Informing optimal antiplatelet strategies. Clinical and Translational Science. https://doi.org/10.1111/cts.70004

Vancouver

Cavallari LH, Lee CR, Franchi F, Keeley EC, Rossi JS, Thomas CD, et al. Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI ) Registry – Informing optimal antiplatelet strategies. Clinical and Translational Science. 2024. doi:10.1111/cts.70004

BibTeX
@article{Cavallari2024,
  author = {Cavallari, Larisa H and Lee, Craig R and Franchi, Francesco and Keeley, Ellen C and Rossi, Joseph S and Thomas, Cameron D and Gong, Yan and McDonough, Caitrin W and Starostik, Petr and Al Saeed, Maryam J and Been, Latonya and Kulick, Natasha and Malave, Jean and Mulrenin, Ian R and Nguyen, Anh B and Terrell, Joshua N and Tillotson, Grace and Beitelshees, Amber L and Winterstein, Almut G and Stouffer, George A and Angiolillo, Dominick J},
  title = {Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI ) Registry – Informing optimal antiplatelet strategies},
  journal = {Clinical and Translational Science},
  year = {2024},
  doi = {10.1111/cts.70004}
}
Kostenlos starten →